Search by Drug Name or NDC
NDC 00173-0874-14 Arnuity Ellipta 100 ug/1 Details
Arnuity Ellipta 100 ug/1
Arnuity Ellipta is a RESPIRATORY (INHALATION) POWDER in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by GlaxoSmithKline LLC. The primary component is FLUTICASONE FUROATE.
MedlinePlus Drug Summary
Fluticasone oral inhalation is used to prevent difficulty breathing, chest tightness, wheezing, and coughing caused by asthma in adults and children. It is in a class of medications called corticosteroids. Fluticasone works by decreasing swelling and irritation in the airways to allow for easier breathing.
Related Packages: 00173-0874-14Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Fluticasone Oral Inhalation
Product Information
NDC | 00173-0874 |
---|---|
Product ID | 0173-0874_424438a1-6362-4694-b20c-7d2fba714d20 |
Associated GPIs | 44400033108020 |
GCN Sequence Number | 072722 |
GCN Sequence Number Description | fluticasone furoate BLST W/DEV 100 MCG INHALATION |
HIC3 | B6M |
HIC3 Description | GLUCOCORTICOIDS, ORALLY INHALED |
GCN | 37007 |
HICL Sequence Number | 034756 |
HICL Sequence Number Description | FLUTICASONE FUROATE |
Brand/Generic | Brand |
Proprietary Name | Arnuity Ellipta |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | fluticasone furoate |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | POWDER |
Route | RESPIRATORY (INHALATION) |
Active Ingredient Strength | 100 |
Active Ingredient Units | ug/1 |
Substance Name | FLUTICASONE FUROATE |
Labeler Name | GlaxoSmithKline LLC |
Pharmaceutical Class | Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC] |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA205625 |
Listing Certified Through | 2024-12-31 |
Package
NDC 00173-0874-14 (00173087414)
NDC Package Code | 0173-0874-14 |
---|---|
Billing NDC | 00173087414 |
Package | 1 INHALER in 1 CARTON (0173-0874-14) / 14 POWDER in 1 INHALER |
Marketing Start Date | 2014-08-20 |
NDC Exclude Flag | N |
Pricing Information | N/A |